3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Hepatocellular
2
Vomiting
1
Pancreatic Neoplasms
1
Neoplasms
1
Nausea
1
Diarrhea
1
Constipation
1
Carcinoma, Non-Small-Cell Lung
1
Cachexia
1
Breast Neoplasms
1
Interventions
Exercise
8
Standard of Care
5
trametinib
3
tislelizumab
3
Radiotherapy
3
Radiosurgery
3
Palliative Care
3
Paclitaxel
3
Gemcitabine
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
cemiplimab
2
Therapeutics
2
Surveys and Questionnaires
2
Resistance Training
2
Oxaliplatin
2
Nivolumab
2
Maintenance
2
Immune Checkpoint Inhibitors
2
Drug Therapy
2
Cisplatin
2
Carboplatin
2
vedolizumab
1
toripalimab
1
surufatinib
1
sparsentan
1
sintilimab
1
semaglutide
1
posaconazole
1
pomalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms
×
Fecal Microbiota Transplantation
×
Clear all
NCT07533227
2026-04-16
FMT-CACH
Changzhou No.2 People's Hospital
Phase 2
Not yet recruiting
66 enrolled